Deleterious versus protective autoimmunity in multiple sclerosis
- PMID: 25944389
- DOI: 10.1016/j.cellimm.2015.04.006
Deleterious versus protective autoimmunity in multiple sclerosis
Abstract
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of central nervous system, in which myelin specific CD4(+) T cells have a central role in orchestrating pathological events involved in disease pathogenesis. There is compelling evidence that Th1, Th9 and Th17 cells, separately or in cooperation, could mediate deleterious autoimmune response in MS. However, the phenotype differences between Th cell subpopulations initially employed in MS pathogenesis are mainly reflected in the different patterns of inflammation introduction, which results in the development of characteristic pathological features (blood-brain barrier disruption, demyelination and neurodegeneration), clinically presented with MS symptoms. Although, autoimmunity was traditionally seen as deleterious, some studies indicated that autoimmunity mediated by Th2 cells and T regulatory cells could be protective by nature. The concept of protective autoimmunity in MS pathogenesis is still poorly understood, but could be of great importance in better understanding of MS immunology and therefore, creating better therapeutic strategies.
Keywords: Multiple sclerosis; Protective autoimmunity; Regulatory T cells; Th1 cells; Th17 cells; Th2 cells; Th9 cells.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. J Neurol Sci. 2013. PMID: 23578791 Free PMC article. Review.
-
IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.Cytokine Growth Factor Rev. 2014 Aug;25(4):403-13. doi: 10.1016/j.cytogfr.2014.07.013. Epub 2014 Jul 29. Cytokine Growth Factor Rev. 2014. PMID: 25153998 Review.
-
Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.Scand J Immunol. 2011 Jul;74(1):1-13. doi: 10.1111/j.1365-3083.2011.02536.x. Scand J Immunol. 2011. PMID: 21338381 Review.
-
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.Ann Neurol. 2009 Sep;66(3):390-402. doi: 10.1002/ana.21748. Ann Neurol. 2009. PMID: 19810097
-
B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.J Immunol. 2015 Oct 15;195(8):3584-95. doi: 10.4049/jimmunol.1402746. Epub 2015 Sep 16. J Immunol. 2015. PMID: 26378076
Cited by
-
Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging.Oncotarget. 2017 Jan 24;8(4):7116-7137. doi: 10.18632/oncotarget.12572. Oncotarget. 2017. PMID: 27738345 Free PMC article. Review.
-
The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis.J Immunol Res. 2024 Jan 4;2024:5383099. doi: 10.1155/2024/5383099. eCollection 2024. J Immunol Res. 2024. PMID: 38213874 Free PMC article. Review.
-
Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas.Histochem Cell Biol. 2016 Oct;146(4):467-77. doi: 10.1007/s00418-016-1455-2. Epub 2016 Jun 9. Histochem Cell Biol. 2016. PMID: 27278446
-
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis.Mediators Inflamm. 2015;2015:475158. doi: 10.1155/2015/475158. Epub 2015 Dec 7. Mediators Inflamm. 2015. PMID: 26770017 Free PMC article. Review.
-
Effector T Cells in Multiple Sclerosis.Cold Spring Harb Perspect Med. 2018 Apr 2;8(4):a029025. doi: 10.1101/cshperspect.a029025. Cold Spring Harb Perspect Med. 2018. PMID: 29358315 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials